Document is current
Any future updates will be listed below
-
Authors
Devulder, Astrid
Vanderlinden, Greet
Cleeren, Evy
Goovaerts, Valerie
Theys, Tom
Van Laere, Koen
Van Paesschen, Wim
-
Funding
Funding for this research was provided by:
Internal Funds KU Leuven (C24/18/097)
- License Information
-
More Information
Article History
Received: 16 July 2024
Accepted: 26 November 2024
First Online: 18 December 2024
Declarations
:
: Written informed consent was obtained for all procedures from the participant and caregiver. The study was approved by the Ethical Committee of University Hospitals Leuven (clinical.trials.gov NCT03617497).
: Patient gave written informed consent for publication of the manuscript.
: K.V.L. has contract research through Leuven Research and Development with BMS, Cerevel and Janssen Pharmaceuticals and is advisory board member for <sup>18</sup>F-MK6240 for Cerveau-Enigma. W.V.P. has grant for Toegepast Biomedisch Onderzoeks-Fonds voor Wetenschappelijk Onderzoek (FWO-TBM) (T000423N) and receives consulting fees from Angeline Pharma, UCB Pharma and Byteflies. The other authors have nothing to report.
